Medtox Scientfic (AMEX:TOX)
Historical Stock Chart
From Jun 2019 to Jun 2024
![Click Here for more Medtox Scientfic Charts. Click Here for more Medtox Scientfic Charts.](/p.php?pid=staticchart&s=A%5ETOX&p=8&t=15)
MEDTOX Scientific Announces Year-End Conference Call
The MEDTOX Year-End Conference Call Will Be Held on Tuesday, March 2 At 9:30 am
Central Time; Year-End Results Are Scheduled for Release Before Market Opening
on March 2, 2004.
ST. PAUL, Minn., Feb. 24 /PRNewswire-FirstCall/ -- MEDTOX Scientific, Inc.
announced today that it will hold a teleconference to discuss year-end results
on March 2, at 9:30 a.m. Central Time (10:30 a.m. Eastern). MEDTOX is scheduled
to release financial results for the year at approximately 6:00 a.m. CST on
March 2.
The conference call can be heard by dialing (800) 387-5648 a few minutes prior
to the scheduled start time on March 2. International callers should dial (706)
634-5527. Callers should ask for the MEDTOXquarterly conference call hosted by
Dick Braun, president and CEO of MEDTOX.
A simultaneous webcast of the conference call will be available on the MEDTOX
website within the "investors" section at http://www.medtox.com/ .
An audio replay of the conference call will be available through March 9 at
(800) 642-1687, Conference ID # 5489284. International callers may access the
replay at (706) 645-9291, with the same Conference ID # 5489284.
MEDTOX Scientific, Inc., headquartered in St. Paul, Minn., is a provider of high
quality specialized laboratory and on-site/point-of-collection (POC) devices.
The company also supports customers with complete logistics, data and program
management services. MEDTOX develops and manufactures diagnostic devices for
quick and economical on-site/point-of-collection analysis for drugs of abuse,
therapeutic drugs and biological and agricultural toxins and provides employment
drug screening and occupational health testing. MEDTOX is a leader in providing
esoteric laboratory testing services to hospitals and laboratories nationwide.
This includes both central laboratory and bio-analytical testing for
pharmaceutical clinical trials. For more information see http://www.medtox.com/
.
DATASOURCE: MEDTOX Scientific, Inc.
CONTACT: Stephen Anderson of MEDTOX Scientific, Inc., +1-877-715-7236
Web site: http://www.medtox.com/